Imperial College London
Clinical trials sponsored by Imperial College London, explained in plain language.
-
Immunotherapy shows promise for mysterious cancers
Disease control CompletedThis study tested the drug pembrolizumab in 35 adults with cancer of unknown primary (CUP), a type of cancer where doctors cannot find where it started. The goal was to see if the drug could shrink tumors and improve survival. Participants received pembrolizumab intravenously, ei…
Phase: PHASE2 • Sponsor: Imperial College London • Aim: Disease control
Last updated Apr 26, 2026 19:35 UTC
-
Heart-Healthy supplement put to the test against common painkiller
Knowledge-focused CompletedThis study looked at whether the amino acid arginine could prevent blood vessel damage caused by the painkiller celecoxib (a type of NSAID). 44 healthy men took celecoxib with either arginine or a placebo for a week. Researchers measured changes in blood vessel function and stiff…
Phase: PHASE4 • Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated May 06, 2026 16:04 UTC